$LOAN
Manhattan Bridge Capital Inc Stock $loan

$loan Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000114420414063785 Filed on October 30, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q4
Revenue	$900.0K	$765.7K	$590.0K
YoY Change	52.54%	30.88%	13.46%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$320.0K	$200.0K	$290.0K
YoY Change	10.34%	17.65%	-9.38%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change
% of Gross Profit
Operating Expenses	$320.0K	$210.0K	$280.0K
YoY Change	14.29%	23.53%	-12.5%
Operating Profit		$417.8K
YoY Change		42.59%
Interest Expense	-$180.0K	-$140.0K	-$120.0K
YoY Change	50.0%	16.67%	33.33%
% of Operating Profit		-33.51%
Other Income/Expense, Net	$0.00	$10.00K	$10.00K
YoY Change	-100.0%	0.0%	0.0%
Pretax Income	$400.0K	$424.7K	$150.0K
YoY Change	166.67%	41.61%	36.36%
Income Tax	$0.00	-$4.291K	$90.00K
% Of Pretax Income	0.0%	-1.01%	60.0%
Net Earnings	$400.0K	$429.0K	$60.00K
YoY Change	566.67%	121.23%	100.0%
Net Earnings / Revenue	44.44%	56.03%	10.17%
Basic Earnings Per Share		$0.08
Diluted Earnings Per Share	$65.90K	$0.08	$13.99K
COMMON SHARES
Basic Shares Outstanding	6.060M shares	5.487M shares
Diluted Shares Outstanding		5.527M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.00K	$60.00K	$1.020M
YoY Change	-95.1%	-14.29%	325.0%
Cash & Equivalents	$47.68K	$60.08K	$1.021M
Short-Term Investments
Other Short-Term Assets	$27.00K	$51.72K	$18.54K
YoY Change	45.6%	29.29%	-1.92%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$19.43M	$18.07M	$11.91M
YoY Change	63.13%	55.24%	4.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$19.09K		$0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$70.00K	$210.0K	$210.0K
YoY Change	-66.67%	-16.0%	-16.0%
Other Assets	$0.00	$10.00K	$0.00
YoY Change		-50.0%	-100.0%
Total Long-Term Assets	$5.017M	$5.458M	$4.215M
YoY Change	19.03%	26.92%	45.53%
TOTAL ASSETS
Total Short-Term Assets	$19.43M	$18.07M	$11.91M
Total Long-Term Assets	$5.017M	$5.458M	$4.215M
Total Assets	$24.44M	$23.53M	$16.12M
YoY Change	51.6%	47.6%	12.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$160.0K	$40.00K	$60.00K
YoY Change	166.67%	100.0%	-14.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$2.469M	$2.319M	$1.319M
YoY Change	87.16%	75.72%	-5.72%
Long-Term Debt Due	$7.700M	$7.000M	$5.350M
YoY Change	43.93%	32.08%	33.75%
Total Short-Term Liabilities	$10.58M	$9.644M	$7.232M
YoY Change	46.27%	36.21%	23.4%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.58M	$9.644M	$7.232M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$10.58M	$9.640M	$7.230M
YoY Change	46.33%	36.16%	23.38%
SHAREHOLDERS EQUITY
Retained Earnings	$113.3K	$141.3K	-$487.7K
YoY Change	-123.24%	-128.08%	-48.26%
Common Stock	$14.12M	$14.11M	$9.750M
YoY Change	44.85%	44.94%	0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$369.3K	$369.3K	$369.3K
YoY Change	0.0%	0.0%	36.8%
Treasury Stock Shares	177.0K shares	177.0K shares	177.0K shares
Shareholders Equity	$13.87M	$13.88M	$8.893M
YoY Change
Total Liabilities & Shareholders Equity	$24.44M	$23.53M	$16.12M
YoY Change	51.6%	47.6%	12.45%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q4
OPERATING ACTIVITIES
Net Income	$400.0K	$429.0K	$60.00K
YoY Change	566.67%	121.23%	100.0%
Depreciation, Depletion And Amortization			$0.00
YoY Change
Cash From Operating Activities	$500.0K	$410.0K	$240.0K
YoY Change	108.33%	36.67%	9.09%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$880.0K	-$6.080M	$710.0K
YoY Change	-223.94%	398.36%	-175.53%
Cash From Investing Activities	-$900.0K	-$6.080M	$710.0K
YoY Change	-226.76%	398.36%	-175.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	400.0K	5.590M	10.00K
YoY Change	3900.0%	-5690.0%	-98.67%
NET CHANGE
Cash From Operating Activities	500.0K	410.0K	240.0K
Cash From Investing Activities	-900.0K	-6.080M	710.0K
Cash From Financing Activities	400.0K	5.590M	10.00K
Net Change In Cash	-0.00000000005821	-80.00K	960.0K
YoY Change	-100.0%	-92.16%	3100.0%
FREE CASH FLOW
Cash From Operating Activities	$500.0K	$410.0K	$240.0K
Capital Expenditures	-$20.00K
Free Cash Flow	$520.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	294000	USD
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	1065312	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	293034	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	20661	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1085973	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60083	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1021023	USD
CY2014Q3	loan	Short Term Loans Receivable ShortTermLoansReceivable	17764285	USD
CY2014Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	193333	USD
CY2013Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	171483	USD
CY2014Q3	us-gaap	Other Assets Current OtherAssetsCurrent	51717	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	18540	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	18069418	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	11908996	USD
CY2014Q3	loan	Investment In Real Estate InvestmentInRealEstate	146821	USD
CY2013Q4	loan	Investment In Real Estate InvestmentInRealEstate	146821	USD
CY2014Q3	loan	Long Term Loans Receivable LongTermLoansReceivable	5239050	USD
CY2013Q4	loan	Long Term Loans Receivable LongTermLoansReceivable	3997000	USD
CY2014Q3	us-gaap	Security Deposit SecurityDeposit	6816	USD
CY2013Q4	us-gaap	Security Deposit SecurityDeposit	6637	USD
CY2014Q3	us-gaap	Cost Method Investments CostMethodInvestments	65000	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	65000	USD
CY2014Q3	us-gaap	Assets Assets	23527105	USD
CY2013Q4	us-gaap	Assets Assets	16124454	USD
CY2014Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	2319465	USD
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1319465	USD
CY2014Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7000000	USD
CY2013Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5350000	USD
CY2014Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	42658	USD
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4256190	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	177000	shares
CY2014Q3	loan	Jointly Funded Loans Total JointlyFundedLoansTotal	5955000	USD
CY2014Q3	loan	Jointly Funded Loans JointlyFundedLoans	3415000	USD
CY2013Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	24504	shares
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	39304	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4289225	shares
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	57066	USD
CY2014Q3	loan	Deferred Origination Fees DeferredOriginationFees	281566	USD
CY2013Q4	loan	Deferred Origination Fees DeferredOriginationFees	132017	USD
CY2014Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	373219	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9643689	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7231767	USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	6236	USD
CY2014Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14105240	USD
CY2014Q3	us-gaap	Treasury Stock Value TreasuryStockValue	369335	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	141275	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	13883416	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23527105	USD
CY2014Q3	loan	Additional Construction Loan For Borrowers Subject To Conditions AdditionalConstructionLoanForBorrowersSubjectToConditions	2511500	USD
CY2011Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	675000	USD
CY2011Q1	loan	Option Sold OptionSold	3900	USD
CY2011Q1	loan	Option Monthly Fee OptionMonthlyFee	10530	USD
CY2014Q3	loan	Exercise Price Of Remaining Property ExercisePriceOfRemainingProperty	146821	USD
CY2014Q3	loan	Monthly Option Fee For Property After Partial Exercise Of Option MonthlyOptionFeeForPropertyAfterPartialExerciseOfOption	2296	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4273544	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5487494	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15681	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	47626	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4727966	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4287698	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5526798	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	266319	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	47696	shares
CY2013Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	257496	shares
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	39374	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	285000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	49000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	147000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	110000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	108000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.97
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.92
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.75
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.59
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M7D
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.58
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y9M11D
	loan	Share Based Compensation Expense ShareBasedCompensationExpense	22048	USD
	loan	Share Based Compensation Expense ShareBasedCompensationExpense	17799	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.75	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.595	pure
CY2013Q3	loan	Share Based Compensation Expense ShareBasedCompensationExpense	13530	USD
CY2014Q3	loan	Share Based Compensation Expense ShareBasedCompensationExpense	10967	USD
	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors	The options may vest over a period not to exceed ten years. Stock options under our stock option plan may be awarded to officers, key-employees, consultants and non-employee directors of the Company. Under our stock option plan, every non-employee director of the Company is granted 7,000 options upon first taking office, and then 7,000 upon each additional year in office.
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0261	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0959	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0107	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.78
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.72
CY2011	loan	Operating Lease Term Of Lease OperatingLeaseTermOfLease	five years and two months
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6236576	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4433190	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6059576	shares
CY2014Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	177000	shares
	loan	Interest Income From Loans InterestIncomeFromLoans	1371420	USD
	loan	Interest Income From Loans InterestIncomeFromLoans	1657076	USD
CY2013Q3	loan	Interest Income From Loans InterestIncomeFromLoans	479118	USD
CY2014Q3	loan	Interest Income From Loans InterestIncomeFromLoans	631640	USD
	loan	Origination Fees OriginationFees	301775	USD
	loan	Origination Fees OriginationFees	347637	USD
CY2013Q3	loan	Origination Fees OriginationFees	105920	USD
CY2014Q3	loan	Origination Fees OriginationFees	134080	USD
	us-gaap	Revenues Revenues	1673195	USD
	us-gaap	Revenues Revenues	2004713	USD
CY2013Q3	us-gaap	Revenues Revenues	585038	USD
CY2014Q3	us-gaap	Revenues Revenues	765720	USD
	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	323478	USD
	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	383721	USD
CY2013Q3	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	119272	USD
CY2014Q3	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	144392	USD
	loan	Referral Fees ReferralFees	1242	USD
	loan	Referral Fees ReferralFees	1049	USD
CY2013Q3	loan	Referral Fees ReferralFees	312	USD
CY2014Q3	loan	Referral Fees ReferralFees	665	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	550145	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	554631	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	172420	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	202822	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	874865	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	939401	USD
CY2013Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	292004	USD
CY2014Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	347879	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	193921	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	798330	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	417841	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	20661	USD
CY2013Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6887	USD
CY2014Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6887	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	818991	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	299921	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	424728	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27709	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	106000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4291	USD
	us-gaap	Net Income Loss NetIncomeLoss	524991	USD
	us-gaap	Net Income Loss NetIncomeLoss	1058264	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	429019	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	32636	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	22048	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	17799	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	12866	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	21850	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16300	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	33357	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-54355	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14409	USD
	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	-38150	USD
	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	-149550	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	11963	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-373219	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	546267	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	782778	USD
	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	12020500	USD
	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	18827000	USD
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	10244866	USD
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	10518616	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1775634	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-8308384	USD
	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	1220000	USD
	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	2650000	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	99363	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	85458	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	429329	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1057719	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6564666	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-171648	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-960940	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240693	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69045	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	282037	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	415928	USD
	us-gaap	Interest Paid InterestPaid	290840	USD
	us-gaap	Interest Paid InterestPaid	383721	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	MANHATTAN BRIDGE CAPITAL, INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001080340
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	LOAN
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6059576	shares
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4288765	USD
CY2014Q3	loan	Share Based Compensation Arrangement By Share Based Payment Award Vested And Non Vested Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndNonVestedOptionsOutstandingIntrinsicValue	79622	USD
CY2014Q3	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue	78424	USD

Files In Submission

Name	View Source	Status
0001144204-14-063785-index-headers.html	Edgar Link	pending
0001144204-14-063785-index.html	Edgar Link	pending
0001144204-14-063785.txt	Edgar Link	pending
0001144204-14-063785-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
loan-20140930.xml	Edgar Link	completed
loan-20140930.xsd	Edgar Link	pending
loan-20140930_cal.xml	Edgar Link	unprocessable
loan-20140930_def.xml	Edgar Link	unprocessable
loan-20140930_lab.xml	Edgar Link	unprocessable
loan-20140930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v391725_10q.htm	Edgar Link	pending
v391725_ex10-1.htm	Edgar Link	pending
v391725_ex31-1.htm	Edgar Link	pending
v391725_ex31-2.htm	Edgar Link	pending
v391725_ex32-1.htm	Edgar Link	pending
v391725_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LOAN
Manhattan Bridge Capital Inc Stock $loan

2014 Q4 Form 10-Q Financial Statement

#000114420414063785 Filed on October 30, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN Manhattan Bridge Capital Inc Stock $loan

2014 Q4 Form 10-Q Financial Statement

#000114420414063785 Filed on October 30, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN
Manhattan Bridge Capital Inc Stock $loan